19-39369936-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001384574.2(SAMD4B):c.478T>G(p.Ser160Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000328 in 1,613,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001384574.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAMD4B | NM_001384574.2 | c.478T>G | p.Ser160Ala | missense_variant | Exon 4 of 14 | ENST00000610417.5 | NP_001371503.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SAMD4B | ENST00000610417.5 | c.478T>G | p.Ser160Ala | missense_variant | Exon 4 of 14 | 2 | NM_001384574.2 | ENSP00000484229.1 | ||
SAMD4B | ENST00000596368.1 | c.478T>G | p.Ser160Ala | missense_variant | Exon 2 of 5 | 5 | ENSP00000471509.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250002Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135312
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461670Hom.: 0 Cov.: 31 AF XY: 0.0000316 AC XY: 23AN XY: 727114
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.478T>G (p.S160A) alteration is located in exon 6 (coding exon 2) of the SAMD4B gene. This alteration results from a T to G substitution at nucleotide position 478, causing the serine (S) at amino acid position 160 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at